CINECA IRIS Institutional Research Information System

WILLIAMS, Tracy Ann
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.094
EU - Europa 4.630
AS - Asia 4.176
SA - Sud America 930
OC - Oceania 199
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.457
CN - Cina 2.184
IT - Italia 959
DE - Germania 755
JP - Giappone 632
MX - Messico 400
FR - Francia 358
IE - Irlanda 350
BR - Brasile 336
ES - Italia 330
GB - Regno Unito 256
CO - Colombia 232
TR - Turchia 230
SE - Svezia 211
CA - Canada 192
AU - Australia 189
AT - Austria 185
FI - Finlandia 158
VN - Vietnam 146
IN - India 144
PL - Polonia 141
TW - Taiwan 139
KR - Corea 135
AR - Argentina 131
HK - Hong Kong 129
NL - Olanda 116
UA - Ucraina 105
GR - Grecia 103
TH - Thailandia 91
CH - Svizzera 89
CL - Cile 88
SG - Singapore 78
BE - Belgio 73
RU - Federazione Russa 68
PT - Portogallo 67
PE - Perù 66
RO - Romania 59
CZ - Repubblica Ceca 47
EC - Ecuador 45
MY - Malesia 39
ID - Indonesia 35
DZ - Algeria 32
IL - Israele 27
DK - Danimarca 24
SA - Arabia Saudita 23
BG - Bulgaria 22
HU - Ungheria 21
AE - Emirati Arabi Uniti 20
HR - Croazia 20
IR - Iran 20
NO - Norvegia 20
BA - Bosnia-Erzegovina 19
MA - Marocco 18
RS - Serbia 17
TN - Tunisia 16
ZA - Sudafrica 16
LT - Lituania 15
PH - Filippine 15
JO - Giordania 14
IQ - Iraq 11
NZ - Nuova Zelanda 10
SK - Slovacchia (Repubblica Slovacca) 10
VE - Venezuela 10
DO - Repubblica Dominicana 8
EG - Egitto 8
SI - Slovenia 8
CR - Costa Rica 7
KW - Kuwait 7
LB - Libano 7
MT - Malta 7
PA - Panama 7
PY - Paraguay 7
QA - Qatar 7
SV - El Salvador 7
UY - Uruguay 7
BO - Bolivia 6
HN - Honduras 6
SN - Senegal 6
IS - Islanda 5
KZ - Kazakistan 5
OM - Oman 5
UG - Uganda 5
BY - Bielorussia 4
GE - Georgia 4
KE - Kenya 4
KH - Cambogia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
BN - Brunei Darussalam 3
EU - Europa 3
MK - Macedonia 3
MM - Myanmar 3
NG - Nigeria 3
NI - Nicaragua 3
PK - Pakistan 3
PR - Porto Rico 3
ZM - Zambia 3
BD - Bangladesh 2
CM - Camerun 2
ET - Etiopia 2
Totale 15.130
Salva come PNG Salva come JPEG
Città #
Beijing 456
Chandler 394
Fairfield 346
Dublin 327
Houston 273
Wilmington 248
Torino 240
Redwood City 207
Ashburn 205
Ann Arbor 193
Munich 182
Vienna 166
Seattle 164
Shanghai 164
Woodbridge 164
Cambridge 140
Tokyo 135
Medford 115
Bogotá 98
Chongqing 95
Villeurbanne 95
Princeton 92
Mexico City 86
Warsaw 84
Buenos Aires 79
Guangzhou 79
Turin 79
Chengdu 78
Dong Ket 77
Madrid 76
Taipei 73
Pisa 71
Nyköping 70
São Paulo 66
Istanbul 64
Nanjing 63
Changsha 62
Jacksonville 61
Santiago 61
Barcelona 53
Dearborn 53
Lima 51
Hangzhou 50
Milan 49
New York 49
Central 45
Ankara 44
London 41
Paris 41
Sydney 40
Singapore 39
Athens 37
Bangkok 37
Berlin 36
Bologna 36
Fremont 35
Medellín 35
Norwalk 35
Rome 35
San Diego 33
Hebei 32
Monterrey 32
Montreal 32
Padova 32
Falls Church 30
Guadalajara 30
Tianjin 30
Wuhan 30
Rochester 29
Santiago de Cali 29
Zhengzhou 29
Brisbane 27
Düsseldorf 27
Boston 26
Dresden 26
Würzburg 26
Perth 25
Prague 25
Shenyang 25
Bucharest 23
Helsinki 23
Melbourne 23
Moscow 23
Chicago 22
Ho Chi Minh City 22
Kuala Lumpur 22
Rio de Janeiro 22
Seoul 22
Shenzhen 22
Izmir 21
Los Angeles 21
Mumbai 21
Quito 21
Belo Horizonte 20
Toronto 20
Valencia 20
Zurich 20
Delhi 19
Porto 19
Zapopan 19
Totale 7.589
Salva come PNG Salva come JPEG
Nome #
Diagnosis and treatment of primary aldosteronism 5.093
Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in pr imar y aldosteronism 656
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice 609
Guidelines for primary aldosteronism: uptake by primary care physicians in Europe 565
The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism 475
Mass spectrometry-based adrenal venous steroid profiling for subtyping primary aldosteronism 365
Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism 314
Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas 300
Subtype Diagnosis of Primary Aldosteronism: Approach to Different Clinical Scenarios 295
Prediction of hyperaldosteronism subtypes when adrenal vein sampling is unilaterally successful 290
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. 286
Coexisting prolactinoma and primary aldosteronism: Is there a pathophysiological link? 272
Primary aldosteronism in the elderly 240
Is there a role for genomics in the management of hypertension? 211
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma 210
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism 205
Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary? 195
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas 182
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro 170
KCNJ5 mutations are the most frequent genetic alteration in primary aldosteronism 136
Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism 133
A Novel Y152C KCNJ5 Mutation Responsible for Familial Hyperaldosteronism Type III 129
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer 127
Aldosterone does not modify gene expression in human endothelial cells 126
Classification of microadenomas in patients with primary aldosteronism by steroid profiling 122
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions 113
Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit 113
Familial hyperaldosteronism type III 111
Assessing outcomes after adrenalectomy for unilateral primary aldosteronism 104
Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism 103
Is Primary Aldosteronism Still Largely Unrecognized? 102
Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism 100
Genetic and Potential Autoimmune Triggers of Primary Aldosteronism 99
Comparative genomics and transcriptome profiling in primary aldosteronism 98
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge kir3.4 residue. 94
Disordered CYP11B2 Expression in Primary Aldosteronism 92
Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism 91
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis 90
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms 83
Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells 82
Steroid Hormone Production in Patients with Aldosterone Producing Adenomas 74
The Adrenal Gland: Central Relay in Health and Disease 74
18-Oxocortisol and 18-hydroxycortisol: Is there clinical utility of these steroids? 73
Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure 73
Mouse models of primary aldosteronism: From physiology to pathophysiology 69
Steroid profiling as an additional tool to confirm one-sided hormone overproduction in primary aldosteronism: A case report 69
In situ metabolomics of aldosterone-producing adenomas 67
Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism 63
Visinin-Like 1 Is Upregulated in Aldosterone-Producing Adenomas With KCNJ5 Mutations and Protects From Calcium-Induced Apoptosis. 62
Effect of Dietary Sodium Modulation on Pig Adrenal Steroidogenesis and Transcriptome Profiles 62
Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). 61
Role of KCNJ5 in familial and sporadic primary aldosteronism. 60
Conceptual basis and methodology of the SOPHIA study 60
Diagnosis and management of primary aldosteronism: The endocrine society guideline 2016 revisited 59
Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT) 59
Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification 56
Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas 54
Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism 54
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism 52
Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension 50
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism 46
Characterization of Circulating Extracellular Vesicle Surface Antigens in Patients With Primary Aldosteronism 46
Clinical Score and Machine Learning-Based Model to Predict Diagnosis of Primary Aldosteronism in Arterial Hypertension 46
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability 45
Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth 45
Familial hyperaldosteronism type III 43
International histopathology consensus for unilateral primary aldosteronism 43
BEX1 Is Differentially Expressed in Aldosterone-Producing Adenomas and Protects Human Adrenocortical Cells from Ferroptosis 42
KCNJ5 Mutations: Sex, Salt and Selection 41
KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism 40
Primary aldosteronism: Metabolic reprogramming and the pathogenesis of aldosterone-producing adenomas 40
Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations 40
Renin and aldosterone measurements in the management of arterial hypertension 37
Familial Hyperaldosteronism Type I 35
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 35
Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients 33
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. 33
Is familial hyperaldosteronism underdiagnosed in hypertensive children? 32
Progress in Primary Aldosteronism 2019: New Players on the Block? 31
Part I: Adrenal HypertensionChapter 1:Primary aldosteronism: Progress in Diagnosis, Therapy, and Genetics. 29
Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status 29
Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: The SOPHIA study 24
Timeline of Advances in Genetics of Primary Aldosteronism 24
Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake 24
Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism 22
Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension 18
Translational Control of Aldosterone Production in Aldosterone-Producing Adenomas 15
Diagnosis and Treatment of Primary Aldosteronism in 2017: Did We Achieve Our Goals? 15
Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism—a Review 15
Visualizing adrenal steroids in primary aldosteronism the expected and the unexplained 13
Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism 11
Recent Developments in Primary Aldosteronism 11
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study 8
Whole blood methylome-derived features to discriminate endocrine hypertension 6
Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation 5
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas 4
Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy 3
Totale 15.461
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019281 0 0 0 0 0 0 0 0 0 0 196 85
2019/20201.452 71 45 71 118 106 278 111 137 155 108 105 147
2020/20211.668 99 149 143 87 160 136 115 82 116 201 151 229
2021/20221.822 134 220 101 153 161 123 108 92 110 144 179 297
2022/20233.747 176 131 133 339 286 500 348 314 335 283 418 484
2023/20244.542 515 530 474 463 476 484 416 452 157 511 64 0
Totale 15.461